CHRNA5 and lung cancer: Interestingly, in our studies, CHRNA5 rs3841324 combined variant genotypes (ins/del+del/del) had an increased NPC risk compared to ins allele homozygotes, which is inconsistent with the results for lung cancer in which the del allele was a protective factor for a Caucasian population [6], [36].